In fact, all patients with DM were comprehensively evaluated by Internal Medicine Unit staff with the following aims: (1) to prescribe tailored perioperative, continued intravenous administration of 5% glucose solution, KCl, and short- and long-acting insulin (adjusted based on periodic measurement of the capillary glucose), and (2) to assess and correct metabolic alterations typically found in such patients. The gene discussed is INS; the disease is diabetes mellitus.